Oral tofacitinib (Xeljanz), a JAK inhibitor, helped regrow hair in three quarters of pediatric patients with alopecia areata (AA) in a small study conducted at the University of Colorado and published in Pediatric Dermatology.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045